awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44096551-64A03497-0121-4240-996F-EDA0F9291E5F
Q44096551-64A03497-0121-4240-996F-EDA0F9291E5F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44096551-64A03497-0121-4240-996F-EDA0F9291E5F
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.
P2860
Q44096551-64A03497-0121-4240-996F-EDA0F9291E5F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44096551-64A03497-0121-4240-996F-EDA0F9291E5F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
20f1171c7362c340064bbf1cc465ef76c2826de5
P2860
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials